Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

Retinal Dystrophies Clinical Trials

6 recruiting trials for Retinal Dystrophies. Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
6
Total Trials
6
Recruiting Now
0
Phase 3 Trials
4
Sponsors

Recruiting Trials

RECRUITINGNCT02014389

Evaluation of Objective Perimetry Using Chromatic Multifocal Pupillometer

Objective perimetry can better monitor visual field defects in retinal dystrophy and Glaucoma patients than conventional subjective perimetry. The PLR ( Pupil Light Reflex to...

Sponsor: Sheba Medical CenterEnrolling: 2001 location
RECRUITINGPhase 1NCT06455826

MAD of IVT VP-001 in PRPF31 Mutation-Associated Retinal Dystrophy Subjects (Wallaby)

A Phase 1 Open-Label, Multiple Ascending Dose Study to Evaluate the Safety and Tolerability of Intravitreally Administered VP-001 in Participants with Confirmed PRPF31...

Sponsor: PYC TherapeuticsEnrolling: 125 locations
RECRUITINGPhase 1NCT06319872

The Effects of Disulfiram (Antabuse®) on Visual Acuity in Patients With Retinal Degeneration

Oral disulfiram (Antabuse®) has been shown to improve image-forming vision in animal models with retinal degeneration due to its ability to decrease Retinoic Acid synthesis and...

Sponsor: University of RochesterEnrolling: 151 location
RECRUITINGPhase 1 / Phase 2NCT06852963

A Repeat-Dose, Open-Label, Two Arm Safety and Efficacy Study of Two Doses of VP-001 Administered Intravitreally in...

This is a Phase 1/2 repeat-dose, open-label, two-arm, parallel group safety and efficacy study of two doses of VP-001 (30 μg and 75 μg) in participants with confirmed PRPF31...

Sponsor: PYC TherapeuticsEnrolling: 166 locations
RECRUITINGNCT06375239

Observational Study to Assess Endpoint Operational Feasibility & Measurement Properties in Patients with Retinal...

The Vision Research and Assessment Institute (VRAI) was established with the purpose of serving as a testing facility for efficacy endpoints for patients with Low Vision. The...

Sponsor: Ray Therapeutics, Inc.Enrolling: 1201 location
RECRUITINGNCT07502664

Development and Evaluation of Functional Visual Field and Navigation Endpoints in Moderate to Profound Inherited...

The Vision Research and Assessment Institute (VRAI) was established with the purpose of serving as a testing facility for efficacy endpoints for patients with Low Vision. The...

Sponsor: Ray Therapeutics, Inc.Enrolling: 251 location